Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Shapiro

Showing results (91-100 of 414) with videos related to

Pageof 42
Sort By:
The American Journal of Gastroenterology|December 2, 2004
Carcinoid tumors and fibrosis: an association with no explanationIrvin M Modlin, Michael D Shapiro, Mark Kidd
World Journal of Surgery|December 16, 2004
An analysis of rare carcinoid tumors: clarifying these clinical conundrumsIrvin M Modlin, Michael D Shapiro, Mark Kidd
Trends in Cardiovascular Medicine|June 2, 2019
The PCSK9 revolution: Current status, controversies, and future directionsBruce A Warden, Sergio Fazio, Michael D Shapiro
The Annals of Pharmacotherapy|July 26, 2019
The Role of the Clinical Pharmacist in a Preventive Cardiology PracticeBruce A Warden, Michael D Shapiro, Sergio Fazio
Ear, Nose, & Throat Journal|September 27, 2006
Primary carcinoid tumor of the parotid gland: A case report and review of the literatureIrvin M Modlin, Michael D Shapiro, Mark Kidd
Annals of Internal Medicine|January 8, 2019
Brief Commentary: Marijuana and Cardiovascular Disease-What Should We Tell Patients?Tina M Kaufman, Sergio Fazio, Michael D Shapiro
European Cardiology|October 20, 2023
The Role of Triglyceride-rich Lipoproteins and Their Remnants in Atherosclerotic Cardiovascular DiseaseMohanad Gabani, Michael D Shapiro, Peter P Toth
Journal of the American College of Cardiology|June 3, 2026
The Expanding Oral Options for LDL Cholesterol Management: Ain't No Cholesterol High Enough, Ain't No Target Low Enough!Liam R Brunham, Michael D Shapiro, Vijay Nambi
Heart (British Cardiac Society)|May 2, 2023
Familial hypercholesterolaemia and emerging therapeuticsFrancisco I Farias, Samuel M Kim, Michael D Shapiro
Annals of Internal Medicine|November 29, 2017
Diagnosing Resistance to a Proprotein Convertase Subtilisin/Kexin Type 9 InhibitorMichael D Shapiro, Joshua Miles, Hagai Tavori, et al.
Pageof 42

Showing results (91-100 of 414) with videos related to

Sort By:
Pageof 42
The American Journal of Gastroenterology|December 2, 2004
Carcinoid tumors and fibrosis: an association with no explanationIrvin M Modlin, Michael D Shapiro, Mark Kidd
World Journal of Surgery|December 16, 2004
An analysis of rare carcinoid tumors: clarifying these clinical conundrumsIrvin M Modlin, Michael D Shapiro, Mark Kidd
Trends in Cardiovascular Medicine|June 2, 2019
The PCSK9 revolution: Current status, controversies, and future directionsBruce A Warden, Sergio Fazio, Michael D Shapiro
The Annals of Pharmacotherapy|July 26, 2019
The Role of the Clinical Pharmacist in a Preventive Cardiology PracticeBruce A Warden, Michael D Shapiro, Sergio Fazio
Ear, Nose, & Throat Journal|September 27, 2006
Primary carcinoid tumor of the parotid gland: A case report and review of the literatureIrvin M Modlin, Michael D Shapiro, Mark Kidd
Annals of Internal Medicine|January 8, 2019
Brief Commentary: Marijuana and Cardiovascular Disease-What Should We Tell Patients?Tina M Kaufman, Sergio Fazio, Michael D Shapiro
European Cardiology|October 20, 2023
The Role of Triglyceride-rich Lipoproteins and Their Remnants in Atherosclerotic Cardiovascular DiseaseMohanad Gabani, Michael D Shapiro, Peter P Toth
Journal of the American College of Cardiology|June 3, 2026
The Expanding Oral Options for LDL Cholesterol Management: Ain't No Cholesterol High Enough, Ain't No Target Low Enough!Liam R Brunham, Michael D Shapiro, Vijay Nambi
Heart (British Cardiac Society)|May 2, 2023
Familial hypercholesterolaemia and emerging therapeuticsFrancisco I Farias, Samuel M Kim, Michael D Shapiro
Annals of Internal Medicine|November 29, 2017
Diagnosing Resistance to a Proprotein Convertase Subtilisin/Kexin Type 9 InhibitorMichael D Shapiro, Joshua Miles, Hagai Tavori, et al.
Pageof 42